Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

OPENing biological barriers using Shell-Engineered Shape-Adaptable Microbubble Enhancers

Project description

Microbubles unlocking next-gen drug delivery

Delivering drugs effectively across biological barriers, such as the blood-brain barrier or dense tumour tissue, remains a challenge. Therapies may fail because they cannot reach their intended targets in sufficient doses without causing harmful side effects. Ultrasound-responsive microbubbles can work to temporarily open pathways for drugs to penetrate otherwise resistant tissues. The ERC-funded Open-SESAME project is developing a modular microbubble platform. Researchers will refine scalable synthesis methods, test performance in brain and tumour models, and strengthen intellectual property for future commercialisation. By combining preclinical validation with market analysis, Open-SESAME aims to deliver an investor-ready plan that could transform treatment for patients with high unmet medical needs.

Objective

OPEN-SESAME will assess the technical and commercial feasibility of a modular microbubble platform technology to enhance the delivery of drugs across biological barriers. The project aims to: (i) establish a robust and scalable synthesis protocol for producing shell- and shape-optimized polymeric microbubbles; (ii) evaluate the preclinical performance of our ultrasound-responsive microbubble enhancers in brain and tumor mouse models; (iii) strengthen our intellectual property (IP) position through freedom-to-operate investigation and generation of new IP on microbubble functionalization; (iv) consult key opinion leaders and perform market analysis of the drug therapy enhancer landscape; and (v) consolidate results in an investor-ready business plan to guide the commercialization of our microbubble platform. We anticipate that by exploiting the technological and socio-economic potential identified in the OPEN-SESAME project, we will create completely new opportunities for the use of microbubbles plus ultrasound to enhance drug delivery and improve therapy outcomes in patients suffering from high-medical-need diseases.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-POC

See all projects funded under this call

Host institution

UNIVERSITAETSKLINIKUM AACHEN
Net EU contribution
€ 150 000,00
Address
Pauwelsstrasse 30
52074 Aachen
Germany
Region
Nordrhein-Westfalen Köln Städteregion Aachen
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)